CanniMed Therapeutics (TSE:CMED) Stock Price Down 5.3%

CanniMed Therapeutics Inc. (TSE:CMEDGet Free Report) shares traded down 5.3% during trading on Monday . The stock traded as low as C$27.00 and last traded at C$27.00. 52,208 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.

CanniMed Therapeutics Price Performance

The firm’s 50-day simple moving average is C$27.00.

CanniMed Therapeutics Company Profile

(Get Free Report)

CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.

Read More

Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with's FREE daily email newsletter.